These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8377367)

  • 1. [The interaction of nonglycoside cardiotonic agents with other drug preparations].
    Grinevich AI; Chekman IS; Roshchupkina EV; Angelutsa PA
    Kardiologiia; 1993; 33(6):56-61. PubMed ID: 8377367
    [No Abstract]   [Full Text] [Related]  

  • 2. Digitalis therapy for patients in clinical heart failure.
    Rahimtoola SH
    Circulation; 2004 Jun; 109(24):2942-6. PubMed ID: 15210610
    [No Abstract]   [Full Text] [Related]  

  • 3. Principles of treatment of left ventricular failure.
    Taylor SH; Silke B; Nelson GI
    Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug therapy of heart failure. Take the chance!].
    Einecke D
    MMW Fortschr Med; 2001 Sep; 143(38):8-10, 12. PubMed ID: 11601101
    [No Abstract]   [Full Text] [Related]  

  • 5. Digitalis pharmacology and therapeutics: recent advances.
    Mason DT
    Ann Intern Med; 1974 Apr; 80(4):520-30. PubMed ID: 4621264
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug therapy for congestive heart failure. Appropriate choices can prolong life.
    Sorrentino MJ
    Postgrad Med; 1997 Jan; 101(1):83-6, 89-90, 93-4. PubMed ID: 9008690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amrinone, a new cardiotonic agent].
    Taira N
    Nihon Rinsho; 1983 Dec; 41(12):2691-7. PubMed ID: 6371299
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
    Kabela E; Michaels DC; Felice EL
    Arch Inst Cardiol Mex; 1979; 49(5):892-907. PubMed ID: 398199
    [No Abstract]   [Full Text] [Related]  

  • 9. [2 mechanisms of the "stimulus-dependent" action of pharmacological agents on the electrical and contractile activity of myocardial cells].
    Khodorov BI
    Kardiologiia; 1980 May; 20(5):7-10. PubMed ID: 6248677
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic management of the myocardial infarction patient after discharge from the hospital.
    Rosman HS; Goldstein S
    Cardiovasc Clin; 1984; 14(3):127-37. PubMed ID: 6144387
    [No Abstract]   [Full Text] [Related]  

  • 11. Digoxin in the management of cardiovascular disorders.
    Gheorghiade M; Adams KF; Colucci WS
    Circulation; 2004 Jun; 109(24):2959-64. PubMed ID: 15210613
    [No Abstract]   [Full Text] [Related]  

  • 12. New catecholamines in clinical cardiovascular medicine.
    Leier CV
    Kardiol Pol; 1980; 23(9):721-5. PubMed ID: 7441942
    [No Abstract]   [Full Text] [Related]  

  • 13. [Principles, methods and criteria for assessing the effectiveness of potentially cardiotonic compounds at the preclinical research stage].
    Chekman IS; Tkachuk VV
    Farmakol Toksikol; 1984; 47(6):5-15. PubMed ID: 6394358
    [No Abstract]   [Full Text] [Related]  

  • 14. [Some advances in cardiovascular pharmacology (author's transl)].
    Ding GS
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):97-103. PubMed ID: 6118953
    [No Abstract]   [Full Text] [Related]  

  • 15. [Principles of the treatment of myocardial failure].
    Korewicki J; Rajecka A; Madeja G
    Kardiol Pol; 1990 Feb; 33(2):126-35. PubMed ID: 2277484
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
    Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
    Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategies for long-term therapy in advanced, chronic heart insufficiency].
    Bleifeld W
    Internist (Berl); 1984 Jul; 25(7):404-14. PubMed ID: 6381368
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiotonic and toxic effects of peruvoside and neriifolin].
    Kao SJ; Zeng GY
    Yao Xue Xue Bao; 1983 Aug; 18(8):572-8. PubMed ID: 6677038
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of ARL 115 BS on parameters of left ventricular contractility in an experimental model of the acute stage of myocardial infarct].
    Cosín J; Caffarena T; Sáez JM; Gimeno JV; Graullera B; Andrés F; Hernándiz A; Solaz J; Martín G; Mainar V
    Rev Esp Cardiol; 1988 Mar; 41(3):168-74. PubMed ID: 3387641
    [No Abstract]   [Full Text] [Related]  

  • 20. [Calcium sensitizers--a new group of drugs that increase myocardium contractility].
    Laine M; Lehtonen L; Nieminen MS
    Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.